<2> Form 13G IN8BIO: A Comprehensive Analysis
<3> Introduction
The Form 13G is a Securities and Exchange Commission (SEC) filing that discloses the ownership of more than 5% of a publicly traded company’s outstanding shares. In this article, we will analyze the Form 13G filing of IN8BIO, a biotechnology company focused on developing innovative treatments for various diseases.
<3> Background on IN8BIO
IN8BIO is a biotechnology company that has been making waves in the industry with its innovative treatments for various diseases. The company’s pipeline includes several promising candidates, which have shown significant potential in clinical trials.
<3> What is Form 13G?
The Form 13G is a SEC filing that is required to be submitted by institutional investors who own more than 5% of a publicly traded company’s outstanding shares. The filing provides detailed information about the investor’s ownership stake, including the number of shares held, the percentage of ownership, and the date of the filing.
<3> IN8BIO Form 13G Analysis
According to the latest Form 13G filing, IN8BIO has several institutional investors who own more than 5% of the